From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,042,000 shares, representing 5.02% for $249.18 million under the buyback announced on March 12, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.11 USD | +0.78% | +1.96% | +25.93% |
29/05 | BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating | MT |
20/05 | Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.93% | 9.06B | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.24B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.76% | 29.99B | |
+15.53% | 25.22B | |
-5.88% | 24.14B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.